Diabetes & Endocrinology Assoc Alabaster, AL - 35007

Diabetes & Endocrinology Assoc is categorized under Internal Medicine Doctors in Alabaster, AL and active since 2001.

Diabetes & Endocrinology Assoc was established in 2001, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact David Morales at the company’s single location by writing to 227 1st St North # B, Alabaster, Alabama AL 35007 or by phoning (205) 664-8888. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Diabetes & Endocrinology Assoc
Contact Person: David Morales
Address: 227 1st St North # B, Alabaster, Alabama 35007
Phone Number: (205) 664-8888
Annual Revenue (USD): $500.000 to $999.999
Founded: 2001
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Diabetes & Endocrinology Assoc was started in 2001 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact David Morales for inquiries that concern Diabetes & Endocrinology Assoc by calling the company number (205) 664-8888, as your correspondence is most welcome. Additionally, the physical location of the single location of Diabetes & Endocrinology Assoc can be found at the coordinates 33.24661,-86.81567 as well as the street address 227 1st St North # B in Alabaster, Alabama 35007.

For its online presence, you may visit Diabetes & Endocrinology Assoc’s website at and engage with its social media outlets through on Twitter and on Facebook.